Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $13.6 Million - $16 Million
-539,400 Reduced 63.11%
315,300 $8.82 Million
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $2.83 Million - $3.25 Million
-109,200 Reduced 11.33%
854,700 $23.7 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $4.71 Million - $6.12 Million
-180,400 Reduced 15.77%
963,900 $27.8 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $940,237 - $1.1 Million
29,300 Added 2.63%
1,144,300 $38 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $28.7 Million - $33.3 Million
795,900 Added 249.42%
1,115,000 $40.9 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $4.92 Million - $6.41 Million
-125,000 Reduced 28.15%
319,100 $13 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $797,425 - $1.04 Million
19,100 Added 4.49%
444,100 $22.8 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $109 Million - $134 Million
-2,501,000 Reduced 85.48%
425,000 $18.6 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $112 Million - $132 Million
2,400,000 Added 456.27%
2,926,000 $153 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $21.8 Million - $27 Million
476,000 Added 952.0%
526,000 $27.2 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $36.4 Million - $54 Million
-881,600 Reduced 94.63%
50,000 $2.95 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $19.4 Million - $22 Million
541,600 Added 138.87%
931,600 $36.5 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $9.38 Million - $10.6 Million
280,000 Added 254.55%
390,000 $14.1 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $3.68 Million - $4.68 Million
110,000 New
110,000 $4.05 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.